Table 1. Clinical characteristics of patients with and without lymph node metastasis in the training and validation cohorts.
Variable | Training cohort (n=233) | Validation cohort (n=101) | |||
---|---|---|---|---|---|
LN− | LN+ | LN− | LN+ | ||
Gender | |||||
Male | 80 | 83 | 31 | 43 | |
Female | 31 | 39 | 10 | 17 | |
Age (years) | |||||
Range | 49–78 | 40–82 | 48–79 | 56–77 | |
Mean ± standard deviation | 65.58±6.58 | 64.07±8.01 | 66.52±7.94 | 66.93±5.70 | |
Location of the tumor | |||||
Upper thoracic esophagus | 15 | 19 | 5 | 7 | |
Middle thoracic esophagus | 79 | 79 | 30 | 38 | |
Lower thoracic esophagus | 17 | 24 | 6 | 15 | |
Lymph node status | 111 | 122 | 41 | 60 | |
Lymph node metastasis | |||||
RLNM | – | 69 | – | 34 | |
NRLNM | – | 53 | – | 26 |
LN, lymph node; +, metastasis positive; −, metastasis negative; RLNM, regional lymph node metastasis; NRLNM, non-regional lymph node metastasis.